Position in LLY
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$13,451,608
+$3,805,061 QoQ
Shares Held
11,215
+6.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
3.33%
of 13F equity value
Holder Rank
#1,092
of 4,605 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Private Wealth Asset Management, LLC holds $31,198,015 across 12 Drug Manufacturers - General names. LLY ranks #1 (43.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
11,215 | $13,451,608 | |
| 2 | ABBV |
AbbVie Inc.
|
24,192 | $6,087,674 | |
| 3 | JNJ |
Johnson & Johnson
|
21,450 | $5,447,656 | |
| 4 | MRK |
Merck & Co., Inc.
|
22,055 | $2,834,067 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
17,470 | $1,006,621 | |
| 6 | PFE |
Pfizer Inc
|
33,487 | $806,366 | |
| 7 | NVS |
Novartis AG
|
3,927 | $615,439 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
3,726 | $470,742 |
All Filings in LLY
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,451,608 | 11,215 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $9,646,547 | 10,488 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $11,143,357 | 10,369 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $7,978,691 | 10,457 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $8,560,018 | 10,981 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $9,107,309 | 11,027 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||